[Skip to Content]
[Skip to Content Landing]
February 25, 1956

Therapy of Fungus Diseases: An International Symposium

JAMA. 1956;160(8):724. doi:10.1001/jama.1956.02960430114030

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Although the emphasis in this symposium was on problems of therapy, epidemiology, biology, ecology, reservoir pathogenicity, and immunization in fungus diseases, a number of factors bearing indirectly on therapy, such as laboratory controls and hormonal influences, were also considered. There was even some speculation as to future lines for study. Some indication of the spirit of the discussions was indicated by Dr. Donald M. Pillsbury, who asked in his introductory remarks: Why are superficial ringworm fungi necrophilic? What are the requirements for the growth of pathogenic fungi? How do the superficial fungi produce their harmful effects? Why is topical therapy for the superficial mycoses so ineffective? What are the host-parasite relationships? In some 54 short papers by authorities actively engaged in mycology, all of these questions and more were considered clearly, concisely, and with wholesome frankness when lack of information dictated it. Nystatin, the antihistamine preparations, the diamidines, nitrostyrenes, and

First Page Preview View Large
First page PDF preview
First page PDF preview